Sphera Funds Management’s Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 OTLKW Stock Holding History

Sphera Funds Management’s Portfolio OTLKW Stock Details OTLKW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-129,500	Closed	-$15K	–	105
2021 Q4	$15K	Hold	129,500	–	–	﹤0.01%	90
2021 Q3	$26K	Hold	129,500	–	–	﹤0.01%	116
2021 Q2	$49K	Hold	129,500	–	–	﹤0.01%	134
2021 Q1	$131K	Hold	129,500	–	–	0.01%	170
2020 Q4	$29K	Hold	129,500	–	–	﹤0.01%	110
2020 Q3	$17K	Hold	129,500	–	–	﹤0.01%	96
2020 Q2	$33K	Hold	129,500	–	–	﹤0.01%	87
2020 Q1	$130K	Buy	+129,500	New	+$15.2K	0.02%	76

Sphera Funds Management's OTLKW Position: Q1 2022 in Review

Sphera Funds Management sold out of Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 (OTLKW) in Q1 2022, closing a stake of 129,500 shares — an estimated $15K sold.

Sphera Funds Management first reported a position in OTLKW in Q1 2020 and held it in 8 quarters. The position peaked at $131K in Q1 2021. 0 funds tracked by Wall St. Rank hold OTLKW as of Q1 2022.

Sphera Funds Management reported no remaining Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 position as of Q1 2022 after selling out during the quarter.
Sphera Funds Management sold 129,500 Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 shares in Q1 2022, an estimated $15K.
Sphera Funds Management first reported a position in Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 in Q1 2020 and held it in 8 quarters.
Sphera Funds Management's Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 position peaked at $131K in Q1 2021.
0 funds tracked by Wall St. Rank held Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022 as of Q1 2022.

Based on Sphera Funds Management's 13F filing for Q1 2022, filed 16 May 2022.